Related Experiment Video

Updated: Jan 30, 2026

Isolation, Fixation and Characterization of Juvenile Gilthead Seabream Head Kidney Leukocytes by Flow Cytometry
08:17

Isolation, Fixation and Characterization of Juvenile Gilthead Seabream Head Kidney Leukocytes by Flow Cytometry

Published on: May 9, 2025

919

French expert opinion for the management of juvenile dermatomyositis

B Bader-Meunier1, C Gitiaux2, A Belot3

  • 1Service d'immunologie, hématologie, rhumatologie pédiatriques, Assistance publique-Hôpitaux de Paris, université Paris V, hôpital Necker-Enfants-Malades, 149, rue de Sèvres, 75015, Paris, France.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|January 15, 2019
PubMed

Insights

This guideline provides expert recommendations for diagnosing and treating juvenile dermatomyositis (JDM). It synthesizes current literature to support clinical management of this rare autoimmune condition in children.

Area of Science:

  • Rheumatology
  • Immunology
  • Pediatrics

Background:

  • Juvenile dermatomyositis (JDM) is a rare autoimmune disease affecting children.
  • Management guidelines are essential for optimal patient outcomes.
  • Expert consensus is needed to address gaps in JDM care.

Purpose of the Study:

  • To develop evidence-based guidelines for JDM diagnosis and treatment.
  • To provide expert recommendations for managing JDM.
  • To inform clinical practice for rare autoimmune diseases.

Main Methods:

  • Systematic literature search (2000-2015) in PubMed.
  • Expert group formation including pediatric rheumatologists, internists, immunologists, physiotherapists, and patient experts.
  • Development of expert opinion on JDM management.

Main Results:

  • Guidelines for the diagnosis of juvenile dermatomyositis.
  • Recommendations for the treatment of juvenile dermatomyositis.
  • Expert consensus on managing JDM.

Conclusions:

  • Established guidelines for JDM diagnosis and treatment.
  • Expert opinion to aid clinicians in managing JDM.
  • Contribution to the FAI2R network's rare disease initiatives.

Keywords:
DermatomyositisJuvenileRecommendations

More Related Videos

Handling and Tagging Techniques for Implanting Juvenile American Shad with a New Acoustic Microtransmitter09:01

Handling and Tagging Techniques for Implanting Juvenile American Shad with a New Acoustic Microtransmitter

Published on: June 14, 2024

2.9K
Implantation of a New Micro Acoustic Tag in Juvenile Pacific Lamprey and American Eel08:36

Implantation of a New Micro Acoustic Tag in Juvenile Pacific Lamprey and American Eel

Published on: March 16, 2019

11.1K

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
429
Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
216
Managing Impressions01:19

Managing Impressions

Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
171
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
634
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
537
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
286